Document ID: chunk:federal_register_of_legislation:F2024C01086:clause:1_37220
Version: federal_register_of_legislation:F2024C01086
Segment Type: clause
Provision Reference: sch 1 cl 37220
Character Range: 1922588–1923988

37220                         Prostate, radioactive seed implantation of, urological component, using transrectal ultrasound guidance:                                                                                                                                                                                                                                                                                                                                                                        1,086.50
                              (a) for a patient with:
                              (i) localised prostatic malignancy at clinical stages T1 (clinically inapparent tumour not palpable or visible by imaging) or T2 (tumour confined within prostate); and
                              (ii) a Gleason score of less than or equal to 7 (Grade Group 1 to Grade Group 3); and
                              (iii) a prostate specific antigen (PSA) of not more than 10ng/ml at the time of diagnosis; and
                              (b) performed by a urologist at an approved site in association with a radiation oncologist; and
                              (c) being a service associated with:
                              (i) services to which items 15966 and 55603 apply; and
                              (ii) a service to which item 60506 or 60509 applies
                              (H) (Anaes.)